Drug
Methyl Aminolevulinate
Methyl Aminolevulinate: highest development phase Approved, developed by Galderma. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Galderma
Trials
| Drug | Phase | Indication |
|---|---|---|
| METVIXIA | Approved |
Latest
No recent events.
Follow Methyl Aminolevulinate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.